Other researches show that activated PROC-PROCR-F2R axis can stimulate the MAPK pathway via activation of epidermal growth factor receptor (EGFR) to promote the progression of breast cancer (Gramling et al., 2010). Here, PROCR is linked to breast carcinoma.